Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Nonrandomized, Open-Label Phase 1 Safety Study of HspE7 and Poly-ICLC Administered Concomitantly in Cervical Intraepithelial Neoplasia (CIN) Subjects

NCT00493545 is registered in ClinicalTrials.gov with Nventa Biopharmaceuticals Corporation as lead sponsor.

NCT NCT00493545
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00493545 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Nonrandomized, Open-Label Phase 1 Safety Study of HspE7 and Poly-ICLC Administered Concomitantly in Cervical Intraepithelial Neoplasia (CIN) Subjects
Lead sponsor
Nventa Biopharmaceuticals Corporation
Phase
Phase 1
Overall status
Unknown status
Start date
May 31, 2007
Completion date
June 30, 2008
Enrollment
24 (estimated)
Sites
8

Conditions

As the registry lists them; a condition with its own page is linked.

cervical intraepithelial neoplasia